Delivering Opioid Use Disorder Care via Telehealth

Since the COVID-19 pandemic and subsequent policy changes regulating the delivery of opioid use disorder treatment, many clinicians have embraced telehealth as a way to decrease barriers to engagement in care. This lecture will orient the audience to the use of telehealth for evidence-based opioid use disorder (OUD) treatment and aims to increase clinician comfort in providing OUD treatment in this way. Objectives Introduce low-barrier buprenorphine treatment approaches, including telehealth. Identify common barriers to receipt of OUD care with buprenporphine and review strategies to make care more accessible. Increase comfort with providing OUD treatment to patients via telehealth modalities. Presenter Shoshana V. Aronowitz, PhD, MSN, MSHP; Department of Family and Community Health, University of Pennsylvania School of Nursing; Philadelphia, Pennsylvania Shoshana is a family nurse practitioner, community-engaged health services researcher, and Assistant Professor in the Department of Family and Community Health at Penn Nursing. Her research examines innovative delivery models to promote equitable access to substance use treatment and harm reduction services. Nursing CE This event is approved for Nursing CE with the California Board of Nursing.